Patents by Inventor Joshua Fuqua

Joshua Fuqua has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS FOR DETECTING VIRUSES
    Publication number: 20230138647
    Abstract: A lateral flow assay and compositions for performing such an assay are described herein that detect whole virus (e.g., HIV, HCV, HSV-2) or viral proteins that use the broad-spectrum anti-viral lectin, griffisthin (GRFT), conjugated to polymeric or gold nanoparticles (NPs) and an appropriate monoclonal antibody (mAb) to confer virus selectivity.
    Type: Application
    Filed: March 25, 2021
    Publication date: May 4, 2023
    Inventors: Joshua Fuqua, Krystal Hamorsky, Kenneth Palmer, Jill M. Steinbach-Rankins
  • ANTI-VIRAL COMPOSITIONS AND METHODS OF MAKING AND USING
    Publication number: 20220289798
    Abstract: Provided herein are GRFT variants and methods of using such GRFT variants. The GRFT variants described herein can be PEGylated, which significantly improves the pharmacokinetics and decreases the immunogenicity of the GFRT composition.
    Type: Application
    Filed: September 10, 2020
    Publication date: September 15, 2022
    Applicants: University of Louisville Research Foundation, Inc., The United States of America, as represented by the Secretary, Department of Health and Human Servic
    Inventors: Joshua Fuqua, Krystal Hamorsky, Barry R. O'Keefe, Tinoush Moulaei, Kenneth E. Palmer
  • COMPOSITIONS FOR MUCUSAL DELIVERY, USEFUL FOR TREATING PAPILLOMAVIRUS INFECTIONS
    Publication number: 20160175426
    Abstract: Polypeptides, compositions, and methods for treatment of papillomavirus (PV) infections including a papillomavirus (PV) minor capsid (L2) polypeptide fragment and a cholera toxin B subunit (CTB) polypeptide are described. Polypeptides and compositions disclosed herein can be administered to the mucosa of a subject, resulting in unexpectedly beneficial production of cross-neutralizing antibodies.
    Type: Application
    Filed: July 16, 2014
    Publication date: June 23, 2016
    Inventors: Kenneth E. Palmer, Nobuyuki Matoba, Joshua Fuqua